OrthoPediatrics Corp. (NASDAQ: KIDS) has recently received a number of price target changes and ratings updates:

  • 11/6/2017 – OrthoPediatrics Corp. is now covered by analysts at BTIG Research. They set a “buy” rating and a $24.00 price target on the stock.
  • 11/6/2017 – OrthoPediatrics Corp. is now covered by analysts at William Blair. They set an “outperform” rating on the stock.
  • 11/6/2017 – OrthoPediatrics Corp. is now covered by analysts at Piper Jaffray Companies. They set an “overweight” rating and a $24.00 price target on the stock.
  • 11/6/2017 – OrthoPediatrics Corp. is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $23.00 price target on the stock.

OrthoPediatrics Corp. (NASDAQ:KIDS) traded up $1.55 during midday trading on Monday, hitting $19.75. The stock had a trading volume of 64,500 shares, compared to its average volume of 88,605. OrthoPediatrics Corp. has a 12 month low of $17.03 and a 12 month high of $23.00.

In related news, Director Harold Ruf bought 11,500 shares of the stock in a transaction dated Monday, October 16th. The stock was bought at an average price of $13.00 per share, with a total value of $149,500.00. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink.

OrthoPediatrics Corp. is a United States-based medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.

Receive News & Ratings for OrthoPediatrics Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics Corp and related companies with MarketBeat.com's FREE daily email newsletter.